title: The expression and activation of ERK/MAPK pathway in human esophageal cancer cell line EC9706.
abstract: While there have been more and more studies concerning mitogen-activated protein kinases (MAPKs) signaling pathways, which control many cellular complex programmes, such as cell proliferation, differentiation, cell death and embryogenesis. However, few studies are carried out about expression and activation of classical MAPKs, extracellular signal-regulated kinase1/2 (ERK1/2) in human esophageal cancer cell line. Therefore, in the present study, we investigated the expression and activation of ERK1/2 in human esophageal cancer cell line EC9706 and human normal esophageal epithelial cell line Heepic, which is as control. This study showed that ERK1/2 was transiently phosphorylated both in EC9706 and Heepic, the kinetics of which were slightly different. To further study the ERK/MAPK signaling pathway in EC9706 and Heepic cell line, U0126 a kind of specific inhibitor of MEK was used. This study showed that U0126 can block the phosphorylation of ERK1/2 in a short time, the complete inhibition concentration for EC9706 and Heepic cell line is 50 and 20 μM, respectively. Incidentally, to further investigate the different roles of ERK1 and ERK2, vector-based short hairpin interference vectors targeted on ERK1/2 was constructed. Moreover, the effective interference target sequence was screened out in a transient transfection manner. MTT experiment showed that ERK2 is more important than ERK1 in the proliferation of EC9706 cells.
authors.affiliation: Medical Research Center, the First Affiliated Hospital, Xinjiang Medical University, Urumqi, 830054, Xinjiang Uygur Autonomous Region, People's Republic of China.
authors.forename: Shu-Tao
authors.initials: ST
authors.lastname: Zheng
authors.forename: Qi
authors.initials: Q
authors.lastname: Huo
authors.forename: Aerziguli
authors.initials: A
authors.lastname: Tuerxun
authors.forename: Wen-Jing
authors.initials: WJ
authors.lastname: Ma
authors.forename: Guo-Dong
authors.initials: GD
authors.lastname: Lv
authors.forename: Cong-Gai
authors.initials: CG
authors.lastname: Huang
authors.forename: Qing
authors.initials: Q
authors.lastname: Liu
authors.forename: Xing
authors.initials: X
authors.lastname: Wang
authors.forename: Ren-Yong
authors.initials: RY
authors.lastname: Lin
authors.forename: Ilyar
authors.initials: I
authors.lastname: Sheyhidin
authors.forename: Xiao-Mei
authors.initials: XM
authors.lastname: Lu
mesh_terms: D001483:Base Sequence; D002070:Butadienes / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004938:Esophageal Neoplasms / Q000378:metabolism*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D020869:Gene Expression Profiling; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D020935:MAP Kinase Signaling System; D008969:Molecular Sequence Data; D009570:Nitriles / Q000494:pharmacology; D010766:Phosphorylation; D015398:Signal Transduction
chemical_list: D002070:Butadienes; D004791:Enzyme Inhibitors; D009570:Nitriles; C113580:U 0126; D048049:Extracellular Signal-Regulated MAP Kinases
references.citation: J Biol Chem. 1999 Sep 10;274(37):26563-71
references.pmid: 10473620
references.citation: Leukemia. 2002 Apr;16(4):486-507
references.pmid: 11960326
references.citation: Cancer Biol Ther. 2005 Sep;4(9):961-7
references.pmid: 16138005
references.citation: Curr Opin Cell Biol. 2001 Apr;13(2):244-8
references.pmid: 11248560
references.citation: Mol Biol Rep. 2009 Feb;36(2):357-64
references.pmid: 18046624
references.citation: Mol Cell Biol. 2008 Jan;28(1):511-27
references.pmid: 17967895
references.citation: Oncogene. 2004 Jan 22;23(3):763-76
references.pmid: 14737111
references.citation: J Am Coll Surg. 2004 Mar;198(3):410-21
references.pmid: 14992744
references.citation: Br J Cancer. 2004 Aug 16;91(4):795-802
references.pmid: 15280923
references.citation: Nat Biotechnol. 2002 May;20(5):446-8
references.pmid: 11981553
references.citation: Mol Biol Rep. 2010 Jan;37(1):363-8
references.pmid: 19757177
references.citation: Cell Death Differ. 2009 Mar;16(3):368-77
references.pmid: 18846109
references.citation: Adv Cancer Res. 1998;74:49-139
references.pmid: 9561267
references.citation: Best Pract Res Clin Gastroenterol. 2007;21(6):921-45
references.pmid: 18070696
references.citation: CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30
references.pmid: 15661684
references.citation: Mol Biol Rep. 2010 Apr;37(4):1971-7
references.pmid: 19649725
references.citation: Biochem Biophys Res Commun. 2008 Aug 8;372(4):845-9
references.pmid: 18533112
references.citation: Cell Growth Differ. 2001 Aug;12(8):397-408
references.pmid: 11504705
references.citation: Oncogene. 2008 Sep 11;27(40):5315-25
references.pmid: 18521085
references.citation: J Neurosci. 2004 Jun 9;24(23):5322-30
references.pmid: 15190104
references.citation: Stem Cells. 2004;22(1):93-9
references.pmid: 14688395
references.citation: Mol Biol Rep. 2010 Jan;37(1):197-205
references.pmid: 19562509
references.citation: Hepatology. 2007 Apr;45(4):1035-45
references.pmid: 17393467
references.citation: J Physiol. 2005 Jul 15;566(Pt 2):409-23
references.pmid: 15890698